Jeil Bio Rises 3.83% Amid Rising Trend of Anthelmintics (Fenbendazole, etc.)

On the 26th, the deworming drug (including Fenbendazole) theme rose by 3.43% compared to the previous day, showing strength, while Jeil Bio, a related stock attracting attention, surged by 3.83% compared to the previous day. Jeil Bio is known as a manufacturer specializing in veterinary pharmaceuticals.

[Graph] Price Fluctuations of Major Stocks in the Deworming Drug (including Fenbendazole) Theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Jeil Bio's quant financial score was 28.75 points, ranking 4th in the quant financial ranking within the deworming drug (including Fenbendazole) related theme. This can be interpreted as Jeil Bio having relatively low investment attractiveness from a financial perspective. On the other hand, Aliko Pharmaceutical ranked 1st in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Score within the Theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.